M&R Capital Management’s AstraZeneca AZN Stock Holding History

M&R Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$8.67M	Sell	55,637 -440	-0.8%	-$71K	1.91%	14
2024 Q2	$8.75M	Buy	56,077 +55,632	+12,502%	+$8.37M	2.09%	12
2024 Q1	$60.2K	Hold	445	–	–	0.01%	215
2023 Q4	$59.9K	Buy	445 +101	+29%	+$13.1K	0.02%	235
2023 Q3	$46.5K	Hold	344	–	–	0.01%	243
2023 Q2	$49.2K	Hold	344	–	–	0.01%	244
2023 Q1	$47.7K	Hold	344	–	–	0.01%	242
2022 Q4	$46.6K	Hold	344	–	–	0.01%	230
2022 Q3	$37K	Hold	344	–	–	0.01%	237
2022 Q2	$45K	Hold	344	–	–	0.01%	233
2022 Q1	$45K	Hold	344	–	–	0.01%	240
2021 Q4	$40K	Hold	344	–	–	0.01%	250
2021 Q3	$41K	Hold	344	–	–	0.01%	243
2021 Q2	$41K	Hold	344	–	–	0.01%	251
2021 Q1	$34K	Hold	344	–	–	0.01%	250
2020 Q4	$34K	Sell	344 -75	-18%	-$7.94K	0.01%	264
2020 Q3	$45K	Buy	419 +75	+22%	+$8.34K	0.01%	248
2020 Q2	$36K	Hold	344	–	–	0.01%	265
2020 Q1	$30K	Hold	344	–	–	0.01%	270
2019 Q4	$34K	Hold	344	–	–	0.01%	294
2019 Q3	$30K	Hold	344	–	–	0.01%	317
2019 Q2	$28K	Hold	344	–	–	0.01%	331
2019 Q1	$26K	Hold	344	–	–	0.01%	334
2018 Q4	$26K	Hold	344	–	–	0.01%	326
2018 Q3	$27K	Hold	344	–	–	0.01%	345
2018 Q2	$24K	Hold	344	–	–	0.01%	353
2018 Q1	$24K	Hold	344	–	–	0.01%	361
2017 Q4	$23K	Buy	+344	New	+$23.2K	0.01%	368

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

M&R Capital Management's AZN Position: Q3 2024 in Review

M&R Capital Management reduced its AstraZeneca (AZN) stake by 0.78% in Q3 2024, selling an estimated $71K and leaving 55,637 shares worth $8.67M. The position accounts for 1.91% of the portfolio, ranked #14.

M&R Capital Management first reported a position in AZN in Q4 2017 and has held it in 28 quarters since. The position peaked at $8.75M in Q2 2024. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

M&R Capital Management held 55,637 shares of AstraZeneca worth $8.67M as of Q3 2024.
M&R Capital Management sold 440 AstraZeneca shares in Q3 2024, an estimated $71K.
AstraZeneca made up 1.91% of M&R Capital Management's portfolio in Q3 2024, its #14 holding.
M&R Capital Management first reported a position in AstraZeneca in Q4 2017 and has held it in 28 quarters since.
M&R Capital Management's AstraZeneca position peaked at $8.75M in Q2 2024.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.